Company profile

Thyme Care

Thyme Care, founded in 2020, raised a $97 million Series D in 2025, giving it a $1.5 billion valuation. The company has raised ~$280 million to date from investors including a16z and Concord Health Partners. Thyme Care delivers personalized oncology care using data driven treatment plans, predictive analytics, and coordinated care teams. Serving thousands of patients, the platform integrates diagnostics, therapy guidance, and continuous monitoring to optimize outcomes. With robust funding and clinical capabilities, Thyme Care is positioned to scale personalized cancer care across the United States.

Back to profiles

Quick facts

Total funding: $97 million
Valuation: $1.5 billion
Founded: 2020

Notable investors

Concord Health Partners

Reach buyers like Thyme Care on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Thyme Care
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Thyme Care.

The 14-day trial ships every feature, no card required.

Start free →